Paper Details

  1. Home
  2. Paper Details

To Bleed or Not to Bleed: That is the Question. The Side Effects of Apixaban.

Author: CicconeMarco Matteo, DevitoFiorella, MaielloMaria, PalmieroPasquale, ZitoAnnapaola

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Apixaban is a new oral anticoagulant (NOACs: Novel Oral Anticoagulant) prescribed to patients with non valvular atrial fibrillation or venous thromboembolism to replace warfarin. Apixaban, compared with warfarin, was associated with a lower rate of intracranial hemorrhages and less adverse consequences following extracranial hemorrhage in the ARISTOTLE Trial.
Paper Details　
Original Abstract of the Article :
Apixaban is a new oral anticoagulant (NOACs: Novel Oral Anticoagulant), like dabigatran, rivaroxaban, and edoxaban. All of them are prescribed to patients with non valvular atrial fibrillation or venous thromboembolism, to replace warfarin, because of the lower probability of bleeding, however they ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/26424386

データ提供：米国国立医学図書館（NLM）

The Double-Edged Sword of Apixaban

Apixaban is a new oral anticoagulant that offers promise in treating conditions like atrial fibrillation and venous thromboembolism. However, this powerful medication comes with a potential for bleeding complications. This review examines the side effects of apixaban, focusing on extracranial and intracranial bleeding. It highlights the importance of careful monitoring and management of bleeding risks associated with apixaban, especially with prolonged use.

Navigating the Desert of Anticoagulation

Apixaban, like a powerful desert wind, can both benefit and harm. While it can help prevent blood clots, it also carries the risk of bleeding. This review underscores the importance of weighing the potential benefits against the risks associated with apixaban, especially when considering prolonged use.

Finding Balance in the Desert of Anticoagulation

This review highlights the double-edged sword of apixaban, reminding us that even powerful tools can have unintended consequences. It's like a camel caravan crossing a vast desert - we must carefully manage the risks and benefits to ensure a safe and successful journey.

Dr.Camel's Conclusion

This review provides valuable insights into the side effects of apixaban, especially regarding bleeding risks. It's like a guidebook for travelers crossing a desert - understanding the potential hazards is essential for a safe journey. By carefully managing bleeding risks and monitoring patients, doctors can help ensure the safe and effective use of apixaban.

Date :
  1. Date Completed 2019-10-16
  2. Date Revised 2019-10-16
Further Info :

Pubmed ID

26424386

DOI: Digital Object Identifier

CDT-EPUB-70790

Related Literature

Article Analysis
・Side Effects of edoxaban
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.